NLRP9P1

Across TCGA pan-cancer cohorts, NLRP9P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated NLRP9P1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher NLRP9P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NLRP9P1 expression acts as an unfavorable survival marker, although some lineages such as LGG and THCA show a favorable association.

KICH, READ, and THYM are the cancer types where NLRP9P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	II,III,IV	0.511	0.894	.001	87	view →
READ	OS	Tertile	II,III,IV	0.214	0.845	<.001	72	view →
THYM	OS	Quartile	All	0.616	1.000	.001	61	view →
ACC	OS	Tertile	All	0.612	0.932	.002	60	view →
KIRC	DFS	Median	All	0.546	0.696	<.001	52	view →
CESC	OS	Tertile	IV	0.140	0.643	<.001	36	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
KIRP	OS	Tertile	All	0.315	0.785	<.001	25	view →
ESCA	OS	Median	All	0.563	1.000	.003	24	view →
LGG	OS	Tertile	All	0.956	0.849	.001	23	view →
THCA	OS	Median	All	0.998	0.981	.006	22	view →
DLBC	DFS	Tertile	IV	0.128	1.000	.017	21	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

NLRP9P1–KICH (OS)

Open the KICH breakdown →